Real-world occurrence, therapy, and outcome of patients with class 2 or 3 BRAF compared with class 1 BRAF-mutated cancers
| Autor: | Pradervand, S., Freundler, N., Gosztonyi, B., Roncoroni, L., Achermann, R., Schwenk, T., de Fraipont, G., Garessus, J., Haefliger, S., Leichtle, A.B., Kiessling, M.K., Mueller-Focke, T., Krebs, F.S., Zoete, V., Tsantoulis, P., Michielin, O., Britschgi, C., Wicki, A. |
|---|---|
| Zdroj: | In ESMO Real World Data and Digital Oncology December 2024 6 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|